New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
08:56 EDTADHDAlcobra releases results from MRI study to evaluate effects of MDX
Alcobra released topline results from a pharmacological MRI study designed to evaluate the regions of the brain that are modulated by MDX. The study evaluated brain response to a single administration of Metadoxine in rats. The results showed that Metadoxine produced a significant, dose-dependent decrease in BOLD signal in highly selective regions of the brain including the prefrontal cortex and showed a statistically significant increase in BOLD response in brain regions including the central nucleus of the amygdala and the lateral hypothalamus. In addition, none of the mesolimbic dopamine system brain regions , known to be involved in the reinforcing effects of scheduled drugs, were significantly affected by Metadoxine at any dose level, which is consistent with previously presented data.
News For ADHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2015
08:50 EDTADHDAlcobra 6.175M share Spot Secondary priced at $6.50
Subscribe for More Information
November 12, 2015
16:06 EDTADHDAlcobra files to sell ordinary shares, no amount given
Jefferies LLC and Barclays Capital Inc. are acting as joint book-running managers for the offering.
16:05 EDTADHDAlcobra reports Q3 EPS (20c), consensus (31c)
Reports Q3 cash and equivalents $35.5M.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use